| Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a … M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ... The Lancet 394 (10214), 2096-2107, 2019 | 691* | 2019 |
| A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer M Altinbas, HS Coskun, O Er, M Ozkan, B Eser, A Unal, M Cetin, S Soyuer Journal of thrombosis and haemostasis 2 (8), 1266-1271, 2004 | 611 | 2004 |
| Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 … MA Dimopoulos, E Terpos, M Boccadoro, S Delimpasi, M Beksac, ... The Lancet Oncology 22 (6), 801-812, 2021 | 294 | 2021 |
| Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ... The Lancet 393 (10168), 253-264, 2019 | 258 | 2019 |
| Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis A Bacigalupo, G Socié, RM Hamladji, M Aljurf, A Maschan, ... haematologica 100 (5), 696, 2015 | 192 | 2015 |
| Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body … A Nagler, V Rocha, M Labopin, A Unal, T Ben Othman, A Campos, L Volin, ... Journal of clinical oncology 31 (28), 3549-3556, 2013 | 183 | 2013 |
| The role of plasma exchange in HELLP syndrome B Eser, M Guven, A Unal, R Coskun, F Altuntas, M Sungur, IS Serin, I Sari, ... Clinical and applied thrombosis/hemostasis 11 (2), 211-217, 2005 | 123 | 2005 |
| A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the … I Sari, F Altuntas, S Hacioglu, I Kocyigit, A Sevinc, S Sacar, K Deniz, E Alp, ... American journal of hematology 83 (4), 334-339, 2008 | 100 | 2008 |
| Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study L Kaynar, F Altuntas, I Aydogdu, B Turgut, I Kocyigit, SK Hacıoglu, ... Transfusion and Apheresis Science 38 (2), 109-115, 2008 | 96 | 2008 |
| Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma S Saarinen, M Aavikko, K Aittomäki, V Launonen, R Lehtonen, K Franssila, ... Blood, The Journal of the American Society of Hematology 118 (3), 493-498, 2011 | 88 | 2011 |
| Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study M Mohty, E Terpos, MV Mateos, M Cavo, S Lejniece, M Beksac, ... Clinical Lymphoma Myeloma and Leukemia 18 (10), e401-e419, 2018 | 79 | 2018 |
| A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome M Beksac, GC Seval, N Kanellias, D Coriu, L Rosiñol, G Ozet, ... Haematologica 105 (1), 201, 2020 | 76 | 2020 |
| Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study F Altuntas, I Aydogdu, S Kabukcu, I Kocyigit, K Cıkım, I Sarı, MA Erkut, ... Transfusion and Apheresis Science 36 (1), 57-67, 2007 | 76 | 2007 |
| Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes A Abaci, Y Yilmaz, M Caliskan, F Bayram, M Cetin, A Unal, S Cetin Thrombosis research 116 (6), 465-470, 2005 | 66 | 2005 |
| Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis E Kaya, M Keklik, M Şencan, M Yilmaz, A Keskin, I Kiki, MA Erkurt, ... Transfusion and Apheresis Science 48 (3), 349-352, 2013 | 64 | 2013 |
| Overexpression of cyclooxygenase‐2 in multiple myeloma: association with reduced survival M Cetin, S Buyukberber, M Demir, I Sari, I Sari, K Deniz, B Eser, F Altuntas, ... American journal of hematology 80 (3), 169-173, 2005 | 61 | 2005 |
| No improvement of survival with reduced-versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients U Thiel, A Wawer, P Wolf, M Badoglio, A Santucci, T Klingebiel, O Basu, ... Annals of oncology 22 (7), 1614-1621, 2011 | 59 | 2011 |
| Pesg PNH diagnosis, follow-up and treatment guidelines F Sahin, OM Akay, M Ayer, MS Dal, S Ertop, O Ilhan, V Karakus, ... American journal of blood research 6 (2), 19, 2016 | 58 | 2016 |
| Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma M Çetin, D Demirci, A Ünal, M Altinbaş, M Güven, K Ünlühizarci Human & experimental toxicology 18 (3), 137-140, 1999 | 50 | 1999 |
| Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing … C Eroglu, C Pala, L Kaynar, K Yaray, MT Aksozen, M Bankir, G Zararsız, ... Leukemia & lymphoma 54 (11), 2474-2479, 2013 | 47 | 2013 |
